Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
1,928.00    36.00 (1.90%)
Bid:
1,912.00
Ask:
1,914.00
Spread: 2.00 (0.105%)
Market Cap: £3.24b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Johnson Matthey Battery Materials update

12 Jan 2022 14:19

RNS Number : 2549Y
Johnson Matthey PLC
12 January 2022
 

12th January 2022

 

Johnson Matthey Plc

(the Company)

Johnson Matthey provides an update on its intention to exit Battery Materials

 

Johnson Matthey, a global leader in sustainable technologies, today provides an update on its intention to exit Battery Materials.

 

On 11th November 2021, we announced our intention to pursue the sale of all or parts of our Battery Materials business with the ultimate intention of exiting. Further to that announcement, we have held discussions with a number of parties about a sale of the entire business. These discussions have not resulted in an agreement to sell the entire business as a going concern. Consequently, we are announcing today that we are commencing consultation with our employees about our proposed closure of the Battery Materials business, and we are pursuing the sale of its individual assets.

 

In our interim results we fully impaired the carrying value of our battery materials assets as at 30th September 2021, resulting in a charge of £314 million. While the outcome of the sales process is uncertain, full or partial closure will result in additional impairment charges, the settlement of contractual liabilities, redundancy, closure and abandonment costs as we indicated at our interim results on 24th November 2021. After anticipated asset disposal proceeds, we currently estimate these cash costs will be in the order of £150 million, which will be recorded as an exceptional item outside of underlying operating profit in our full year results.

 

 

ENDS

 

Enquiries: 

Investor Relations

Martin Dunwoodie

Louise Curran

Carla Fabiano

 

Director of Investor Relations

Senior Investor Relations Manager

Senior Investor Relations Manager

 

+44 20 7269 8241

+44 20 7269 8235

+44 20 7269 8004

 

Media

Barney Wyld

Harry Cameron

 

 

Group Corporate Affairs Director

Tulchan Communications

 

 

+44 7485 337498

+44 20 7353 4200

 

 

 

 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774Legal Entity Identifier number: 2138001AVBSD1HSC6Z10

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEALFAFFXAEFA
Date   Source Headline
3rd Aug 20224:31 pmRNSDirector/PDMR Shareholding
3rd Aug 20224:23 pmRNSDirector/PDMR Shareholding
3rd Aug 20224:21 pmRNSDirector/PDMR Shareholding
3rd Aug 20224:04 pmRNSDirector/PDMR Shareholding
3rd Aug 20223:59 pmRNSDirector/PDMR Shareholding
3rd Aug 20223:50 pmRNSDirector/PDMR Shareholding
3rd Aug 20223:41 pmRNSDirector/PDMR Shareholding
1st Aug 20227:00 amRNSJM restated HY numbers for new reporting structure
29th Jul 20222:49 pmRNSHolding(s) in Company
27th Jul 20224:15 pmRNSHolding(s) in Company
27th Jul 20224:00 pmRNSHolding(s) in Company
26th Jul 20223:00 pmRNSHolding(s) in Company
22nd Jul 20223:23 pmRNSDirector/PDMR Shareholding
21st Jul 20224:00 pmRNSResult of AGM
18th Jul 202211:00 amRNSHolding(s) in Company
18th Jul 20227:00 amRNSJohnson Matthey announces new hydrogen gigafactory
15th Jul 20229:12 amRNSHolding(s) in Company
14th Jul 202210:01 amRNSHolding(s) in Company
12th Jul 20224:11 pmRNSHolding(s) in Company
8th Jul 20224:25 pmRNSHolding(s) in Company
8th Jul 202211:00 amRNSHolding(s) in Company
6th Jul 202211:32 amRNSHolding(s) in Company
17th Jun 202211:38 amRNSDirector/PDMR Shareholding
17th Jun 20229:30 amRNSHolding(s) in Company
15th Jun 202210:33 amRNSAnnual Financial Report
14th Jun 202212:45 pmRNSDirector/PDMR Shareholding
10th Jun 20225:21 pmRNSHolding(s) in Company
6th Jun 202211:20 amRNSHolding(s) in Company
1st Jun 20229:00 amRNSTotal Voting Rights
1st Jun 20227:00 amRNSJohnson Matthey completion of Health sale
30th May 202211:20 amRNSDirector/PDMR Shareholding
27th May 20224:50 pmRNSHolding(s) in Company
27th May 20224:48 pmRNSHolding(s) in Company
27th May 20224:45 pmRNSHolding(s) in Company
26th May 20227:00 amRNSJohnson Matthey FY results and strategy update
26th May 20227:00 amRNSJohnson Matthey sale of Battery Materials
25th May 20224:04 pmRNSHolding(s) in Company
25th May 20221:24 pmRNSJohnson Matthey expands presence in green hydrogen
19th May 202210:30 amRNSDirector/PDMR Shareholding
17th May 20224:01 pmRNSHolding(s) in Company
16th May 20227:00 amRNSTransaction in Own Shares
13th May 20227:00 amRNSTransaction in Own Shares
12th May 20227:00 amRNSTransaction in Own Shares
11th May 20227:00 amRNSTransaction in Own Shares
10th May 20227:00 amRNSTransaction in Own Shares
9th May 202211:45 amRNSHolding(s) in Company
9th May 20227:00 amRNSTransaction in Own Shares
4th May 20224:26 pmRNSHolding(s) in Company
3rd May 20225:55 pmRNSHolding(s) in Company
3rd May 20224:04 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.